LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.63
0.00 (0.48%)
At close: Sep 19, 2025, 3:59 PM
0.48% (1D)
| Bid | 0.54 |
| Market Cap | 25.84M |
| Revenue (ttm) | 577.33M |
| Net Income (ttm) | -436.09M |
| EPS (ttm) | -0.73 |
| PE Ratio (ttm) | -0.86 |
| Forward PE | 0.06 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 0.54 |
| Volume | 942,216 |
| Avg. Volume (20D) | 342,418 |
| Open | 0.79 |
| Previous Close | 0.63 |
| Day's Range | 0.63 - 0.79 |
| 52-Week Range | 0.57 - 8.60 |
| Beta | 0.57 |
| Ex-Dividend Date | n/a |
2 months ago
+40.74%
LakeShore Biopharma shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago · businesswire.com
LSB Industries, Inc. to Participate in Upcoming Investor ConferencesOKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”), (NYSE: LXU), today announced that its Chairman & Chief Executive Officer, Mark Behrman will be participating in the following conferences:...
2 months ago · businesswire.com
LSB Industries, Inc. Reports Operating Results for the 2025 Second QuarterOKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Re...
